Beta globin transduced bone marrow cells (San Rocco Therapeutics/Memorial Sloan-Kettering Cancer Center)

N/A

Report date: 2026/04/25 20:00:23

Base Information

Drug NameBeta globin transduced bone marrow cells (San Rocco Therapeutics/Memorial Sloan-Kettering Cancer Center)
Drug Alias NameAutologous CD34+ cells transduced with TNS9.3.55TNS9-3-55 transduced CD34 cellsAutologous CD34+ stem cells2009 EGT-produced vectorAutologous CD34+ stem cells - EGT +[8] 
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsThalassemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesErrant Gene TherapeuticsMemorial Sloan Kettering Cancer Center
Active IndicationsN/A
Inactive IndicationsThalassemia

Other Information

ATC CodeN/A
Related LinksN/A